Evidence map›Paper›PMID 40681080›Full record

ArticleFood and chemical toxicology : an international journal published for the British Industrial Biological Research Association2025

Per- and polyfluoroalkyl substances (PFAS) toxicity and mitigation of adipogenic dysregulation in 3T3-L1 preadipocytes.

Qinfu Wang, Soonkyu Chung, Meichen Wang

Abstract read
In one paragraph

Article in Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Qinfu WangCollege of Basic Medical Science, Hainan Vocational University of Science and Technology, 571137, China.
Soonkyu ChungDepartment of Nutrition, University of Massachusetts Amherst, Amherst, MA, 01003, USA.
Meichen WangDepartment of Environmental Health Sciences, University of Massachusetts Amherst, Amherst, MA, 01003, USA. Electronic address: meichenwang@umass.edu.

Funding

Development of edible sorbent therapies to mitigate dietary exposures to per- and polyfluoroalkyl substances (PFAS)R00ES034090 · NIEHS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI WANG, MEICHEN · 2024 to 2025
$730k
NIEHS NIH HHS R00 ES034090
6 · The paper itself

Abstract

Obesity and metabolic disorders are rising global concerns, with one factor linked to per- and polyfluoroalkyl substances (PFAS), a class of persistent endocrine-disrupting chemicals that affect adipogenic pathways. While PFAS are known to promote terminal lipid accumulation in mature adipocytes, their effects during dynamic adipocyte differentiation, particularly at human-relevant doses and in mixtures, remain poorly understood. This study employed 3T3-L1 preadipocytes to assess PFAS toxicity and mitigation in cell viability, redox balance, mitochondrial integrity, lipid content, and gene expression during differentiation. Repeated, low-dose exposure to 0.1 μM PFAS (individual and mixture) time-dependently reduced cell viability through induced reactive oxygen and nitrogen species by 22-49 % and reduced mitochondrial membrane potential. The 2-4-fold increase in lipid accumulation, especially by PFOA, correlated with Pparγ activation by 47-86 % (r

Indexed as

AdipocytesAdipogenesisFluorocarbons3T3-L1 CellsAnimalsCell DifferentiationCell SurvivalCytokinesLipid MetabolismMembrane Potential, MitochondrialMiceReactive Oxygen SpeciesCytokinesFluorocarbonsReactive Oxygen SpeciesAdipogenesisAdsorptionEndocrine disrupting chemicalsMitochondriaObesityOxidative stressPparγ

Identifiers

PMID40681080
PMCPMC12398223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.